Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

NCT01430585 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Early Breast Cancer (Phase 2)
Advanced Breast Cancer (Phase 1b)

Interventions

DRUG: PF-04691502
DRUG: PF-04691502 in combination with Letrozole
DRUG: Letrozole

Sponsor

Pfizer